Transcat, Inc. (NASDAQ:TRNS) Receives $105.33 Consensus PT from Analysts

Transcat, Inc. (NASDAQ:TRNS) has been assigned an average recommendation of “Moderate Buy” from the five analysts that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, two have given a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $105.3333.

A number of brokerages have recently issued reports on TRNS. Weiss Ratings reissued a “sell (d+)” rating on shares of Transcat in a research note on Monday, December 29th. Zacks Research raised Transcat from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 4th.

Institutional Trading of Transcat

Large investors have recently modified their holdings of the stock. White Pine Capital LLC raised its position in shares of Transcat by 1.7% during the second quarter. White Pine Capital LLC now owns 10,175 shares of the scientific and technical instruments company’s stock worth $875,000 after purchasing an additional 171 shares during the period. Police & Firemen s Retirement System of New Jersey grew its position in Transcat by 14.8% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 2,238 shares of the scientific and technical instruments company’s stock valued at $192,000 after purchasing an additional 288 shares during the period. Deutsche Bank AG grew its position in Transcat by 4.6% in the 4th quarter. Deutsche Bank AG now owns 7,053 shares of the scientific and technical instruments company’s stock valued at $400,000 after purchasing an additional 312 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Transcat by 6.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company’s stock valued at $407,000 after purchasing an additional 325 shares in the last quarter. Finally, Swiss National Bank increased its stake in Transcat by 2.2% during the 4th quarter. Swiss National Bank now owns 18,315 shares of the scientific and technical instruments company’s stock valued at $1,039,000 after purchasing an additional 400 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Transcat Price Performance

Shares of NASDAQ TRNS opened at $71.75 on Tuesday. The company has a market capitalization of $669.43 million, a PE ratio of 84.41 and a beta of 0.71. The company has a quick ratio of 1.85, a current ratio of 2.21 and a debt-to-equity ratio of 0.34. Transcat has a twelve month low of $50.23 and a twelve month high of $97.08. The firm has a fifty day simple moving average of $71.05 and a 200 day simple moving average of $67.28.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings results on Tuesday, February 3rd. The scientific and technical instruments company reported $0.26 EPS for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.04). Transcat had a net margin of 2.47% and a return on equity of 6.15%. The firm had revenue of $83.86 million for the quarter, compared to the consensus estimate of $80.99 million. On average, sell-side analysts forecast that Transcat will post 2.3 EPS for the current year.

Transcat Company Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.